Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 976 participants.
Also called NCT07290751
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 976 participants
- Sponsor
- Registry
-
NCT07290751
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07290751. Randomized; quadruple masking; primary purpose treatment. Start 2025-11-11 (actual); primary completion 2026-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Tirofiban
- Intervention (Other)
- Placebo (0.9% normal saline)
- Lead sponsor
- Beijing Anzhen Hospital
Record details
- Record id
cardio:ct-nct07290751- Content hash
22f4a9398ccf662194f0c2de5ae379ce404063949e9fb23bb14be6971ecf62ed